Does NIH Favor Mediocrity over Meritocracy? | GenomeWeb

A commentary published in Nature this week argues that the National Institutes of Health is not meeting its mandate to fund "the best science, by the best scientists."

Indeed, based on an analysis of 1,380 papers published since 2001 that have received 1,000 citations or more — a "proxy" measurement for the influence of the work — the authors found that "three out of five authors of these influential papers do not currently have NIH funding as principal investigators."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.